Perspectives of brachytherapy: Patterns of care, new technologies, and “new biology“

Cancer/Radiotherapie

Volumn 18, Issue 5-6, 2014, Pages 434-436

  Guedea, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Brachytherapy; Breast; Dose escalation; Gynaecological; Prostate

Indexed keywords

SPHINGOLIPID; STAT3 PROTEIN;

BRACHYTHERAPY; BREAST CANCER; CD8+ T LYMPHOCYTE; CLINICAL PRACTICE; EUROPE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PRACTICE GUIDELINE; PROSTATE CANCER; RADIATION DOSE; REVIEW; SIGNAL TRANSDUCTION; STEREOTACTIC BODY RADIATION THERAPY; BYSTANDER EFFECT; DEVICES; IMAGE GUIDED RADIOTHERAPY; MANAGEMENT; NEOPLASMS; ONCOLOGY; ORGANS AT RISK; PEROPERATIVE CARE; PROCEDURES; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSURGERY; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION;

BRACHYTHERAPY; BYSTANDER EFFECT; DOSE FRACTIONATION; EUROPE; HUMANS; INTRAOPERATIVE CARE; NEOPLASMS; ORGANS AT RISK; PHYSICIAN'S PRACTICE PATTERNS; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RADIATION ONCOLOGY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, IMAGE-GUIDED; SIGNAL TRANSDUCTION;

EID: 84907384006     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2014.07.143     Document Type: Short Survey

References (24)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Chauvet B., Mahé M.A., Maingon P., Mazeron J.J., Mornex F. [White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique]. Cancer Radiother 2013, 17 suppl. 1:S2-S72.
3. Bentzen S.M., Heeren G., Cottier B., Slotman B., Glimelius B., Lievens Y., et al. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiother Oncol 2005, 75:355-365.
4. Heeney C., McClean B., Kelly C. A dosimetric intercomparison of brachytherapy facilities in Ireland, Scotland and the North of England. Radiother Oncol 2005, 74:149-156.
5. Esco R., Palacios A., Pardo J., Biete A., Carceller J.A., Veiras C., et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol 2003, 56:319-327.
6. Ruggieri-Pignon S., Pignon T., Marty M., Rodde-Dunet M.-H., Destembert B., Fritsch B. Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice. Int J Radiat Oncol 2005, 61:507-516.
7. Slotman B.J., Cottier B., Bentzen S.M., Heeren G., Lievens Y., van den Bogaert W. Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: Work package 1. Radiother Oncol 2005, 75:349.E1-349.E6.
8. Slotman B.J., Leer J.W.H. Infrastructure of radiotherapy in the Netherlands: evaluation of prognoses and introduction of a new model for determining the needs. Radiother Oncol 2003, 66:345-349.
9. Guedea F., Venselaar J., Hoskin P., Hellebust T.P., Peiffert D., Londres B., et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol 2010, 97:514-520.
10. Guedea F., Ellison T., Venselaar J., Borras J.M., Hoskin P., Poetter R., et al. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. Radiother Oncol 2007, 82:50-54.
11. Otahal B., Dolezel M., Cvek J., Simetka O., Klat J., Knybel L., et al. Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: a virtual brachytherapy study. Rep Pract Oncol Radiother 2014, 10.1016/j.rpor.2014.04.005.
12. Mazeron J.-J. Brachytherapy: a new era. Radiother Oncol 2005, 74:223-225.
13. Guedea F. Recent developments in brachytherapy. Rep Pract Oncol Radiother 2011, 16:203-206.
14. Janoray G., Chapet S., Ruffier-Loubière A., Bernadou G., Pointreau Y., Calais G. Robotic stereotactic body radiation therapy for tumours of the liver: radiation-induced liver disease, incidence and predictive factors. Cancer Radiother 2014, 18:191-197.
15. Feuvret L., Vinchon S., Martin V., Lamproglou I., Halley A., Calugaru V., et al. Stereotactic radiotherapy for large solitary brain metastases. Cancer Radiother 2014, 18:97-106.
16. Loo B.W. Stereotactic ablative radiotherapy (SABR) for lung cancer: what does the future hold?. J Thorac Dis 2011, 3:150-152.
17. Loo B.W., Chang J.Y., Dawson L.A., Kavanagh B.D., Koong A.C., Senan S., et al. Stereotactic ablative radiotherapy: what's in a name?. Pract Radiat Oncol 2011, 1:38-39.
18. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
19. Fuks Z., Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005, 8:89-91.
20. Brown J.M., Brenner D.J., Carlson D.J. Dose escalation, not “new biology“, can account for the efficacy of SBRT with NSCLC. Int J Radiat Oncol Biol Phys 2013, 85:1159-1160.
21. Demaria S., Ng B., Devitt M.L., Babb J.S., Kawashima N., Liebes L., et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004, 58:862-870.
22. Postow M.A., Callahan M.K., Barker C.A., Yamada Y., Yuan J., Kitano S., et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012, 366:925-931.
23. Belletti B., Vaidya J.S., D'Andrea S., Entschladen F., Roncadin M., Lovat F., et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res 2008, 14:1325-1332.
24. Segatto I., Berton S., Sonego M., Massarut S., Fabris L., Armenia J., et al. p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation. Mol Oncol 2014, 8:766-780.